These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 21154391)

  • 1. De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock.
    Gomes Silva BN; Andriolo RB; Atallah AN; Salomão R
    Cochrane Database Syst Rev; 2010 Dec; (12):CD007934. PubMed ID: 21154391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock.
    Silva BN; Andriolo RB; Atallah AN; Salomão R
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD007934. PubMed ID: 23543557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De-escalation of empiric antibiotics in patients with severe sepsis or septic shock: A meta-analysis.
    Guo Y; Gao W; Yang H; Ma C; Sui S
    Heart Lung; 2016; 45(5):454-9. PubMed ID: 27340006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis, severe sepsis or septic shock.
    Andriolo BN; Andriolo RB; Salomão R; Atallah ÁN
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010959. PubMed ID: 28099689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock.
    Garnacho-Montero J; Gutiérrez-Pizarraya A; Escoresca-Ortega A; Corcia-Palomo Y; Fernández-Delgado E; Herrera-Melero I; Ortiz-Leyba C; Márquez-Vácaro JA
    Intensive Care Med; 2014 Jan; 40(1):32-40. PubMed ID: 24026297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of antimicrobial de-escalation of treatment for sepsis: A protocol for systematic review and meta-analysis.
    Zhu H; Peng P; Zhao R; Fang KY; Han SQ
    Medicine (Baltimore); 2020 Dec; 99(49):e23385. PubMed ID: 33285724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human recombinant activated protein C for severe sepsis.
    Martí-Carvajal AJ; Solà I; Lathyris D; Cardona AF
    Cochrane Database Syst Rev; 2012 Mar; (3):CD004388. PubMed ID: 22419295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroids for treating severe sepsis and septic shock.
    Annane D; Bellissant E; Bollaert PE; Briegel J; Keh D; Kupfer Y
    Cochrane Database Syst Rev; 2004; (1):CD002243. PubMed ID: 14973984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-volume haemofiltration for sepsis.
    Borthwick EM; Hill CJ; Rabindranath KS; Maxwell AP; McAuley DF; Blackwood B
    Cochrane Database Syst Rev; 2013 Jan; (1):CD008075. PubMed ID: 23440825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients.
    Martí-Carvajal AJ; Solà I; Gluud C; Lathyris D; Cardona AF
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD004388. PubMed ID: 23235609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock.
    Alejandria MM; Lansang MA; Dans LF; Mantaring JB
    Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD001090. PubMed ID: 24043371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De-escalation, adequacy of antibiotic therapy and culture positivity in septic patients: an observational study.
    Moraes RB; Guillén JA; Zabaleta WJ; Borges FK
    Rev Bras Ter Intensiva; 2016 Sep; 28(3):315-322. PubMed ID: 27626951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Early and Appropriate Antibiotic Administration Improve Mortality in Emergency Department Patients with Severe Sepsis or Septic Shock?
    Sherwin R; Winters ME; Vilke GM; Wardi G
    J Emerg Med; 2017 Oct; 53(4):588-595. PubMed ID: 28916120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human recombinant activated protein C for severe sepsis.
    Martí-Carvajal A; Salanti G; Cardona AF
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004388. PubMed ID: 17636755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human recombinant activated protein C for severe sepsis.
    Martí-Carvajal AJ; Solà I; Lathyris D; Cardona AF
    Cochrane Database Syst Rev; 2011 Apr; (4):CD004388. PubMed ID: 21491390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human activated protein C for severe sepsis in neonates.
    Kylat RI; Ohlsson A
    Cochrane Database Syst Rev; 2006 Apr; (2):CD005385. PubMed ID: 16625638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human recombinant activated protein C for severe sepsis.
    Martí-Carvajal A; Salanti G; Cardona AF
    Cochrane Database Syst Rev; 2008 Jan; (1):CD004388. PubMed ID: 18254048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early versus late pre-intensive care unit admission broad spectrum antibiotics for severe sepsis in adults.
    Siddiqui S; Razzak J
    Cochrane Database Syst Rev; 2010 Oct; 2010(10):CD007081. PubMed ID: 20927754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collaborative approach of individual participant data of prospective studies of de-escalation in non-immunosuppressed critically ill patients with sepsis.
    Gutiérrez-Pizarraya A; Leone M; Garnacho-Montero J; Martin C; Martin-Loeches I
    Expert Rev Clin Pharmacol; 2017 Apr; 10(4):457-465. PubMed ID: 28266901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin for treating sepsis and septic shock.
    Alejandria MM; Lansang MA; Dans LF; Mantaring JB
    Cochrane Database Syst Rev; 2002; (1):CD001090. PubMed ID: 11869591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.